Does IgE Have a Role in Aspirin-exacerbated Respiratory Disease?

Affiliations

Editorial

William W Busse. Am J Respir Crit Care Med. 2020.

. 2020 Jun 15;201(12):1459-1460.

doi: 10.1164/rccm.202003-0783ED.

¹ Department of MedicineUniversity of Wisconsin School of Medicine and Public HealthMadison, Wisconsin.

No abstract available

Comment on

Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Kamide Y, Nakamura Y, Hamada Y, Tomita Y, Sekiya K, Tsuburai T, Izuhara K, Wakahara K, Hashimoto N, Hasegawa Y, Taniguchi M. Hayashi H, et al. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1488-1498. doi: 10.1164/rccm.201906-1215OC. Am J Respir Crit Care Med. 2020. PMID: 32142372 Free PMC article. Clinical Trial.

1. Laidlaw TM, Boyce JA. Aspirin-exacerbated respiratory disease--new prime suspects. N Engl J Med. 2016;374:484–488. - PubMed
1. Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, et al. Diagnosis and management of NSAID-eacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy. 2019;74:28–39. - PubMed
1. Boyce JA. Aspirin sensitivity: lessons in the regulation (and dysregulation) of mast cell function. J Allergy Clin Immunol. 2019;144:875–881. - PMC - PubMed
1. Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D2: a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135:245–252. - PMC - PubMed
1. Robuschi M, Gambaro G, Sestini P, Pieroni MG, Refini RM, Vaghi A, et al. Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium. Am J Respir Crit Care Med. 1997;155:1461–1464. - PubMed